PP_1170x120_10-25-21

“Prescription Drug Pricing for the People Act”

PCMA supports new legislation that directs FTC to examine anticompetitive practices

PCMA supports new legislation that directs FTC to examine anticompetitive practices

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) released the following statement on S. 1388, the “Prescription Drug Pricing for the People Act.” PCMA, the trade association for America’s pharmacy benefit managers (PBMs), today endorsed S. 1388, the “Prescription Drug Pricing for the People Act,” sponsored by Sen. Charles Grassley (R, Iowa). The bipartisan legislation

Adheris Health